Haemosiderotic fibrolipomatous tumour: an extremely unusual intraosseous presentation.
Roetger N, Shepherd B, Wakefield P.
Pathology. 2023 Feb;55(1):139-141. doi: 10.1016/j.pathol.2022.04.008. Epub 2022 Jul 19.
Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity.
Browne TJ, Fletcher CD.
Histopathology. 2006 Mar;48(4):453-61. doi: 10.1111/j.1365-2559.2006.02360.x.
Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.
Hallor KH, Sciot R, Staaf J, Heidenblad M, Rydholm A, Bauer HC, Aström K, Domanski HA, Meis JM, Kindblom LG, Panagopoulos I, Mandahl N, Mertens F.
J Pathol. 2009 Apr;217(5):716-27. doi: 10.1002/path.2513.
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.
Jo VY, Fletcher CD.
Pathology. 2014 Feb;46(2):95-104. doi: 10.1097/PAT.0000000000000050.
Advances in the clinicopathological and molecular classification of cutaneous mesenchymal neoplasms.
Costigan DC, Doyle LA.
Histopathology. 2016 May;68(6):776-95. doi: 10.1111/his.12930. Epub 2016 Mar 1.
[Fourth edition of WHO classification tumours of soft tissue].
Karanian M, Coindre JM.
Ann Pathol. 2015 Jan;35(1):71-85. doi: 10.1016/j.annpat.2014.11.003. Epub 2014 Dec 17.
